(November 07, 2022 08:01 ET | Source: Iovance Biotherapeutics, Inc. ) Clinically Meaningful and Durable Activity in Largest Cell Therapy…

In this episode, Melissa Wilson, PA-C, MPAS, AIM’s “Ask a Medical Expert” and host of the webinar series, “From the…

By Mara Klecker Madison Goff spent her early teenage years tanning in her family’s tanning bed or laying by the…

October 17th – 23rd, 2022 is National Estate Planning Awareness Week Creating a legacy gift that supports melanoma research in…

While it may be an uncomfortable topic to bring up, sharing your sexual orientation and gender identity with your cancer…

(Source:Georgetown University Medical Center) Originally published Sep 27, 2022, Medical Life Sciences Giving immunotherapy before targeted therapy improves survival in…

by Alicia Rowell, Vice President Saturday, June 4 was a special evening. In Chicago that week many of the nation’s…

From the Desk of Samantha Guild Leaves are falling, pumpkins are out, football is on TV, and the kids are…

By Mara Klecker Ann Garst Taylor, AIM at Melanoma’s new Director of Community Engagement, has nearly 30 years of volunteer…

(NEWS PROVIDED BY  Bristol Myers Squibb, September 16, 2022, ) Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the…